Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Panca Budi Idaman Tbk. (PBID) vs Organon Pharma Indonesia Tbk. (SCPI)

Panca Budi Idaman Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Panca Budi Idaman Tbk. dan Organon Pharma Indonesia Tbk.: Panca Budi Idaman Tbk. diperdagangkan di Rp525 (kapitalisasi pasar 3,98 T, volume 24 jam 658,2 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Panca Budi Idaman Tbk. jauh lebih besar — sekitar 38,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

PBIDSCPI
Kapitalisasi Pasar
3,98 T104,4 M
Volume
658,2 rb
Lot
6,58 rb
Perputaran
346,62 jt
Harga Rata-rata
526,62
Nilai Transaksi
346,62 jt
Harga Ekuilibrium Indikatif
525
Volume Ekuilibrium Indikatif
4

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

PBID
Lihat detail
SCPI
Lihat detail

Tentang Panca Budi Idaman Tbk.

PT Panca Budi Idaman (The Company) was established by Notarial Deed No.16 dated January 10, 1990 made before Notary Endang Irawati Ekaputri, S.H.,which was amended by Notarial Deed No.3 dated July 2, 1997 made before Notary Jenny Jacinta Lukas, S.H., and Deed No. 10 dated October 17, 1997 made before Notary Kiagus Zainal Arifin, S.H. Panca Budi Group was founded by Djonny Taslim in 1979 who started his career as a general merchant distributing plastic bags made from PP, HDPE and PE. In 1990, Djonny Taslim established PT. Panca Budi Idaman ("the Company") to produce and distribute finished products of plastic bags. The Company commenced its commercial operation by producing plastic bags in 1991.

Selengkapnya di halaman PBID

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI